Advertisement
Advertisement

GMAB

GMAB logo

Genmab A/S ADS

28.81
USD
Sponsored
-0.97
-3.26%
Jul 10, 13:17 UTC -4
Open

GMAB Earnings Reports

Positive Surprise Ratio

GMAB beat 26 of 41 last estimates.

63%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.11B
/
$3.48
Implied change from Q1 26 (Revenue/ EPS)
+24.42%
/
+319.28%
Implied change from Q2 25 (Revenue/ EPS)
+20.52%
/
-35.79%

Genmab A/S ADS earnings per share and revenue

On May 07, 2026, GMAB reported earnings of 0.83 USD per share (EPS) for Q1 26, missing the estimate of 1.40 USD, resulting in a -41.03% surprise. Revenue reached 896.00 million, compared to an expected 908.21 million, with a -1.34% difference. The market reacted with a -2.98% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of 3.48 USD, with revenue projected to reach 1.11 billion USD, implying an increase of 319.28% EPS, and increase of 24.42% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Replimune Group, Inc.
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.72
Actual
-$0.76
Surprise
-4.52%
logo
Beyond Air, Inc. Common Stock
Report Date
Jun 26, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.63
Surprise
-9.00%
FAQ
For Q1 2026, Genmab A/S ADS reported EPS of $0.83, missing estimates by -41.03%, and revenue of $896.00M, -1.34% below expectations.
The stock price moved down -2.98%, changed from $27.89 before the earnings release to $27.06 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 6 analysts, Genmab A/S ADS is expected to report EPS of $3.48 and revenue of $1.11B for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement